Two doses of the widely used HPV vaccine Gardasil9 produced an immune response identical to the standard three-dose regimen in women with well-controlled HIV, according to a study by Dr Deborah Konopnicki and colleagues published in the journal Clinical Infectious Diseases.
The World Health Organization (WHO) currently recommends a three-dose schedule for people living with HIV as opposed to two doses in the general population, due to concerns about potentially reduced immune responses. However, the study explored whether two doses might be sufficient for women with HIV who have stable immune function. Their results showed that antibody levels − commonly used as a proxy for vaccine efficacy − were effectively the same in the two- and three-dose groups against all nine types of the virus the vaccine protects against.
Read the full news story at aidsmap.
Source : aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.